Metformin‑induced apoptosis facilitates degradation of the cellular caspase 8 (FLICE)‑like inhibitory protein through a caspase‑dependent pathway in human renal cell carcinoma A498 cells
- 30 May 2018
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 16 (2) , 2030-2038
Abstract
Renal cell carcinoma (RCC) is one of the most common types of cancer in adults. Previous studies have reported that the survival rate was significantly lower for renal cancer patients with diabetes than for those without diabetes. Metformin is a well‑known anti‑diabetic agent used for the treatment of type 2 diabetes mellitus (T2DM). It also inhibits cell proliferation and angiogenesis and is known to possess antitumor effects. However, the molecular mechanism for metformin‑induced apoptosis in renal cell carcinoma is not understood. In the present study, treatment with metformin induced apoptosis in A498 cells in a dose‑dependent manner. It was revealed that degradation of cellular caspase 8 (FLICE)‑like inhibitory protein (c‑FLIP) and activation of procaspase‑8 were associated with metformin‑mediated apoptosis. By contrast, treatment with metformin did not affect the mRNA level of c‑FLIPL in A498 cells. Treatment with benzyloxycarbonyl‑Val‑Ala‑Asp‑fluoromethyl ketone (z‑VAD‑fmk, a pan‑caspase inhibitor) almost completely blocked metformin‑induced apoptosis and degradation of c‑FLIPL protein. However, N‑acetyl‑L‑cysteine (NAC), a reactive oxygen species (ROS) scavenger, did not inhibit metformin‑mediated apoptosis in A498 cells. Taken together, the results of the present study demonstrated that metformin‑induced apoptosis involved degradation of the c‑FLIPL protein and activation of caspase‑8 in human renal cell carcinoma A498 cells and suggested that metformin could be potentially used for the treatment of renal cancer.Keywords
This publication has 50 references indexed in Scilit:
- Risk of Cancer in Diabetes: The Effect of MetforminISRN Endocrinology, 2013
- Calyculin A causes sensitization to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by ROS-mediated down-regulation of cellular FLICE-inhibiting protein (c-FLIP) and by enhancing death receptor 4 mRNA stabilizationApoptosis, 2012
- Reduced Risk of Colorectal Cancer With Metformin Therapy in Patients With Type 2 DiabetesDiabetes Care, 2011
- Insulin receptor and cancerEndocrine-Related Cancer, 2011
- Quercetin downregulates Mcl-1 by acting on mRNA stability and protein degradationBritish Journal of Cancer, 2011
- Cellular FLICE-inhibitory protein (c-FLIP) signalling: A key regulator of receptor-mediated apoptosis in physiologic context and in cancerThe International Journal of Biochemistry & Cell Biology, 2010
- A constitutively active and uninhibitable caspase-3 zymogen efficiently induces apoptosisBiochemical Journal, 2009
- c-FLIPL expression defines two ovarian cancer patient subsets and is a prognostic factor of adverse outcomeEndocrine-Related Cancer, 2009
- Selective Induction of Apoptosis of Human Oral Cancer Cell Lines by Avocado Extracts Via a ROS-Mediated MechanismNutrition and Cancer, 2009
- Caspase‐8 in Apoptosis: The Beginning of “The End”?IUBMB Life, 2000